AGENDA DAY 1

 

 

Day 1 Oct 10th Veterinary

Dr Nathalie Garcon
11:40

Chair’s opening remarks

Panel discussion
Prof Albert Osterhaus
12:45

Virus discovery – new kids on the block with pandemic potential

 
  • Comparing diseases side by side to “human diseases”
  • The importance of pathogen identification with unknown host transfer
13:15

Networking Lunch & Poster Session

Dr Peter Daszak
14:45

The Global Virome Project: Bringing an end to pandemics

 
  • How can this global cooperative scientific reduces the risk of viral outbreaks over the next decade?
  • Challenges in doing so and hurdles needing to be overcome
  • Visionary thoughts for the future
Dr Joseph Domenech
15:15

Use of vaccination in animals for total epizootic disease eradication and anti-microbial resistance control

- Using vaccination as an effective mean to treat bacterial animal infections at the source
- Development of vaccines for decreasing use of antibiotics in terrestrial and aquatic animals
- Using vaccination as a tool for total epizootic disease eradication (Dog Rabies, FMD and PPR)
- Potential within the veterinary vaccine industry and challenges needing to be overcome
 
Dr Adel Talaat
15:45

Nanovaccines; A new platform technology for immunization against avian infections that impact human health

  • Utilizing avian influenza virus (AIV) proteins encapsulated within polyanhydride nanoparticles to develop
    a protective vaccine against outbreaks of high pathogenic and low pathogenic avian influenza
     
16:15

Networking Break

Dr Osama Ahmed Hassan Ahmed
16:45

New insight and the challenges associated with the prevention and control of Rift Valley fever

 
  • New research and new data updates
  • The significant role of early detection, notification and information sharing during transboundary disease outbreak
  • Discussing the need to employ a “One Health” approach and update on recent efforts to control the recent outbreak of RVF in West Africa using the One Health approach
  • Reassessing the current vaccination strategy for RVF
Dr Nikolai Petrovsky
17:15

Development of proprietary polysaccharide vaccine adjuvants that meet the needs of humans and animals when concerning Influenza, West Nile and other re-emerged viruses

 
  • Novel adjuvant combinations for veterinary and human vaccines
  • Production of vaccines in line with One Health considerations
  • Challenges faced, overcome and needing to be overcome for accelerated commercialisation and market access
17:45

Chair closing remarks of day one followed by Drinks Reception

last published: 05/Oct/17 16:46 GMT